Perform Another (Advanced) Search

1.  Study Posting (1360) Trial #151295, Head and Neck Cancer, Lexington, KY
...with a cancer of the head and neck such as: the mouth, tongue, nasal cavity, pharynx, throat, larynx, or tonsil; and • are over the age of 18. Persons who are eligible ...
View Page

2.  Study Posting (4812) Trial #115167, Head and Neck Cancer, Chicago, IL
...II-III (T2-T3, N0-1MO) carcinoma of the head and neck, including oral cavity, pharynx larynx, paranasal sinuses and cervical esophagus.  Selected patients with stage IV disease (T4N0-1M0) will ...
View Page

3.  Newly Approved Drug Therapies (604) Tri-Nasal Spray (triamcinolone acetonide spray), Muro Pharmaceutical,
...placebo. Side Effects In rare cases, the development of localized infections of the nose and pharynx has occurred. It has been shown in clinical studies that intranasal corticosteroids may cause a ...
View Page

4.  Newly Approved Drug Therapies (732) Teveten (eprosartan mesylate plus hydrochlorothiazide), Unimed Pharmaceuticals,
...mesylate use in clinical trials include: • Upper respiratory tract infection • Rhinitis • Pharyngitis (inflammation of the pharynx) • Cough • Fatigue • Abdominal pain • Joint pain Mechanism of Action Angiotensin II, a potent vasoconstrictor, is ...
View Page

5.  Newly Approved Drug Therapies (738) Tracleer (bosentan), Actelion,
...include (but are not limited to) the following: • Headache • Nasopharyngitis (inflammation of the nose and pharynx) • Flushing • Edema, lower limb • Hypotension • Palpitations Women who are pregnant, or who may become pregnant ...
View Page

6. Clinical Trial Results by Drug Names
...of adverse events were similar between the treatment groups, with the following exceptions: diarrhea, vomiting, pharynx dysesthesia and palmar-plantar erythrodysesthesia (PPE) occurred with a higher incidence in the XELOX group ...
View Page